Tang, W., Yu, X., Zeng, R., & Chen, L. (2020). LncRNA-ATB Promotes Cisplatin Resistance in Lung Adenocarcinoma Cells by Targeting the miR-200a/β-Catenin Pathway. Cancer Manag Res.
Stile di citazione ChicagoTang, Weiwei, Xiuyi Yu, Ru Zeng, e Lilin Chen. "LncRNA-ATB Promotes Cisplatin Resistance in Lung Adenocarcinoma Cells By Targeting the MiR-200a/β-Catenin Pathway." Cancer Manag Res 2020.
Citazione MLATang, Weiwei, Xiuyi Yu, Ru Zeng, e Lilin Chen. "LncRNA-ATB Promotes Cisplatin Resistance in Lung Adenocarcinoma Cells By Targeting the MiR-200a/β-Catenin Pathway." Cancer Manag Res 2020.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.